Preliminary study of substantia nigra analysis by tensorial feature extraction-Reference-Cited by-同舟云学术

Preliminary study of substantia nigra analysis by tensorial feature extraction

Published:2024-06-27 Issue: Volume: Page:
ISSN:1861-6429
Container-title:International Journal of Computer Assisted Radiology and Surgery
language:en
Short-container-title:Int J CARS

Author:

Itoh Hayato^ORCID,Oda Masahiro,Saiki Shinji,Kamagata Koji,Sako Wataru,Ishikawa Kei-ichi,Hattori Nobutaka,Aoki Shigeki,Mori Kensaku

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11548-024-03175-2.pdf

Reference29 articles.

1. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, Abdollahpour I, Abdulkader RS, Abebe Z, Abera SF, Abil OZ, Abraha HN, Abu-Raddad LJ, Abu-Rmeileh NME, Accrombessi MMK, Acharya D et al (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. The Lancet 392(10159):1789–1858

2. Berre AL, Kamagata K, Otsuka Y, Andica C, Hatano T, Saccenti L, Ogawa T, Takeshige-Amano H, Wada A, Suzuki M, Hagiwara A, Irie R, Hori M, Oyama G, Shimo Y, Umemura A, Hattori N, Aoki S (2019) Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI. Neuroradiology 61:1387–1395

3. He N, Chen Y, LeWitt PA, Yan F, Haacke EM (2023) Application of neuromelanin MR imaging in Parkinson disease. J Magn Resonance Imaging 57:337–352

4. Sasaki M, Shibata E, Tohyama K (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson’s disease. Neuro Rep 17(11):1215–1218

5. Kashihara K, Shinya T, Higaki F (2011) Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease. J Clin Neurosci 18(8):1093–1096